Skip to main content
Premium Trial:

Request an Annual Quote

Aruna Biomedical Taps RiversEdge BioVentures for Strategic Advisory Services

NEW YORK (GenomeWeb News) - Stem cell research tools company Aruna Biomedical said yesterday that it has hired recently formed life sciences advisory and investment services firm RiversEdge BioVentures to evaluate strategic alternatives for Aruna.

RiversEdge will evaluate potential fundraising opportunities for Aruna, expansion of its strategic partnerships, and potential combinations with strategic and financial investors, among other services.

Aruna, based in Athens, Ga., develops and commercializes products and services from or related to human stem cells for drug discovery and basic research.

Founded in 2003 by Steven Stice, a professor at UGA and director of its Regenerative Bioscience Center, Aruna claims to be the first to commercialize products derived from human embryonic stem cells.

The company has exclusive worldwide licenses from the University of Georgia Research Foundation to develop and commercialize neural cells and human mesenchymal cells derived from hESCs. Aruna also has a nonexclusive license from the Wisconsin Alumni Research Foundation for the use of ESC patents in research applications.

RiversEdge, based in Beaufort, SC, announced its formation earlier this month. Principal and Founder David Dodd previously served as CEO for BioReliance and Serologicals (now part of Millipore); and as non-executive chairman of Stem Cell Sciences, which was sold to Stem Cells Inc. in April.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.